RSS

Ionis Pharmaceuticals

Akcea Therapeutics and Ionis Pharmaceuticals have announced that Tegsedi (inotersen) has received European marketing authorisation approval for the treatment of stage 1 or stage 2 polyneuropathy in adult patients with hATTR more

News

Researchers from the UCL Huntington’s Disease Centre have developed a drug that has been shown to be safe and well-tolerated in its first human trial, successfully lowering the level of harmful huntingtin protein in the nervous system more

News

Gilead Sciences is to pay $200m for infringing upon Merck and Ionis Pharmaceuticals’ Hepatitis C drug patents more

News